19 November 2018
Visiongain has launched a new pharma report:Laboratory Information Systems Market Report: Web-Based, On-Premise Based, Cloud-Based, Software, Hardware, Services, Clinical, Drug Discovery, Industrial.
The laboratory information system ("LIS") industry includes set of programs and hardware, which are part of an integrated system designed for healthcare information. It is an information system intended for capturing complex data and information related to medical and industrial laboratories, including clinical and analytical laboratories. The information system interfaces with analytical instruments and allows users to obtain, store, manage, retrieve and record laboratory data. As industrial and medical laboratories are diverse with different requirements; hence, there is no standard information system designed for laboratories. Therefore, a laboratory information system is customized, developed, and configured according to the requirements of a laboratory.
The lead analyst of the report commented "The global LIS market is currently fragmented in most countries, but few large vendors hold significant market shares. However, many new players are entering the market and the consolidation of small players with larger counterparts is shaping the vendor landscape. Competition is getting intense and key players are trying to sustain themselves by improving their delivery models with increased usage of technology."
Leading companies featured in the report include Abbott Laboratories, Cerner Corporation, Eclipsys Corporation, LabVantage Solutions, Inc., LabWare, Inc., McKesson Corporation, Medical Information Technology, Inc., Thermo Fisher Scientific
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.
12 April 2021
Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.
09 April 2021
The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.
06 April 2021
Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.